Actively Recruiting
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
Led by Attikon Hospital · Updated on 2025-05-31
15
Participants Needed
2
Research Sites
179 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.
CONDITIONS
Official Title
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years
- Karnofsky Performance Score of 50 or more
- Newly diagnosed, histologically confirmed glioblastoma grade 4, or secondary metastases or progression after surgical resection, radiation, and chemotherapy
- Normal liver and kidney function
- Ability to sign informed consent form
You will not qualify if you...
- Diabetes mellitus
- Life expectancy greater than 3 months
- Inability to adhere to the diet
- Inability to give informed consent form
- Cholecystectomy within the last year before study entry
- Diagnosis of genetic disorder of fat metabolism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Arezina Kasti
Chaïdári, Athens, Greece, 12461
Actively Recruiting
2
Attikon University General Hospital
Athens, Greece, 12462
Actively Recruiting
Research Team
A
Arezina N. Kasti, RD
CONTACT
E
Evangelos K. Papadopoulos, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here